Literature DB >> 35704752

Evaluation of the Effect of Macrocyclic Ring Size on [203Pb]Pb(II) Complex Stability in Pyridyl-Containing Chelators.

Brooke L McNeil1,2, Karthika J Kadassery3, Anthony W McDonagh1, Wen Zhou1, Paul Schaffer1,2,4, Justin J Wilson3, Caterina F Ramogida1,2.   

Abstract

As an element-equivalent theranostic pair, lead-203 (203Pb, 100% EC, half-life = 51.92 h) and lead-212 (212Pb, 100% β-, half-life = 10.64 h), through the emission of γ rays and an α particle in its decay chain, respectively, can aid in the development of personalized targeted radionuclide treatment for advanced and currently untreatable cancers. With these isotopes currently being used in clinical trials, an understanding of the relationship between the chelator structure, ability to incorporate the radiometal, and metal-complex stability is needed to help design appropriate chelators for clinical use. Herein, we report an investigation into the effect of ring size in macrocyclic chelators where pyridine, an intermediate Lewis base, acts as an electron donor toward lead. Crown-4Py (4,7,13,16-tetrakis(pyridin-2-ylmethyl)-1,10-dioxa-4,7,13,16-tetraazacyclooctadecane), cyclen-4Py (1,4,7,10-tetrakis(pyridin-2-ylmethyl)-1,4,7,10-tetraazacyclododecane), and NOON-2Py (7,16-bis(pyridin-2-ylmethyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane) were synthesized and analyzed for their ability to coordinate Pb2+. Metal complex stability was investigated via [203Pb]Pb2+ radiolabeling studies, 1H NMR spectroscopy, X-ray crystallography, and potentiometry. With the smallest macrocyclic backbone, cyclen-4Py had the highest radiochemical yield, while, in descending order, crown-4Py and NOON-2Py had the lowest. Thermodynamic stability constants (log KML) of 19.95(3), 13.29(5), and 11.67 for [Pb(Cyclen-4Py)]2+, [Pb(Crown-4Py)]2+, and [Pb(NOON-2Py)]2+, respectively, correlated with their radiochemical yields. The X-ray crystal structure of the least stable complexes [Pb(NOON-2Py)]2+ revealed a hemidirected Pb2+ center, as reflected by a void within the coordination sphere, and [Pb(Crown-4Py)]2+ showed an average Pb-N pyridine interatomic distance of >3 Å. By contrast, the crystal structure of [Pb(Cyclen-4Py)]2+ showed shorter Pb-N pyridine interactions, and in solution, only one highly symmetric isomer existed for this complex, whereas conformational flexibility was observed for both [Pb(Crown-4Py)]2+ and [Pb(NOON-2Py)]2+ at the NMR timescale. This study illustrates the importance of the macrocyclic backbone size when incorporating bulky electron-donor groups into the design of a macrocyclic chelator as it affects the accessibility of lead to the donor arms. Our results show that cyclen-4Py is a promising chelator for future studies with this theranostic pair.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35704752      PMCID: PMC9366509          DOI: 10.1021/acs.inorgchem.2c01114

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.436


  21 in total

1.  Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs.

Authors:  P Gans; A Sabatini; A Vacca
Journal:  Talanta       Date:  1996-10       Impact factor: 6.057

2.  GLEE, a new computer program for glass electrode calibration.

Authors:  P Gans; B O'Sullivan
Journal:  Talanta       Date:  2000-01-24       Impact factor: 6.057

3.  Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta Ray Banerjee; Mrudula Pullambhatla; Catherine A Foss; Alexander Falk; Youngjoo Byun; Sridhar Nimmagadda; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2013-07-22       Impact factor: 7.446

4.  Synthesis and characterization of nitrogen-rich macrocyclic ligands and an investigation of their coordination chemistry with lanthanum(III).

Authors:  Justin J Wilson; Eva R Birnbaum; Enrique R Batista; Richard L Martin; Kevin D John
Journal:  Inorg Chem       Date:  2014-12-19       Impact factor: 5.165

5.  Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of 225 Ac-crown-αMSH Peptide.

Authors:  Hua Yang; Chengcheng Zhang; Zheliang Yuan; Cristina Rodriguez-Rodriguez; Andrew Robertson; Valery Radchenko; Randy Perron; Denise Gendron; Patrick Causey; Feng Gao; François Bénard; Paul Schaffer
Journal:  Chemistry       Date:  2020-08-28       Impact factor: 5.236

6.  Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb.

Authors:  L L Chappell; E Dadachova; D E Milenic; K Garmestani; C Wu; M W Brechbiel
Journal:  Nucl Med Biol       Date:  2000-01       Impact factor: 2.408

7.  Polyether complexes of groups 13 and 14.

Authors:  Ala'aeddeen Swidan; Charles L B Macdonald
Journal:  Chem Soc Rev       Date:  2016-04-11       Impact factor: 54.564

Review 8.  Theranostic radiopharmaceuticals: established agents in current use.

Authors:  James R Ballinger
Journal:  Br J Radiol       Date:  2018-03-12       Impact factor: 3.039

9.  Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair.

Authors:  Brooke L McNeil; Andrew K H Robertson; Winnie Fu; Hua Yang; Cornelia Hoehr; Caterina F Ramogida; Paul Schaffer
Journal:  EJNMMI Radiopharm Chem       Date:  2021-02-01

10.  Getting a lead on Pb2+-amide chelators for 203/212Pb radiopharmaceuticals.

Authors:  Aidan Ingham; Thomas I Kostelnik; Brooke L McNeil; Brian O Patrick; Neha Choudhary; María de Guadalupe Jaraquemada-Peláez; Chris Orvig
Journal:  Dalton Trans       Date:  2021-08-05       Impact factor: 4.390

View more
  1 in total

1.  Diagnostic and Therapeutic Radiopharmaceuticals.

Authors:  Craig W Lindsley; Christa E Müller; Salvatore Bongarzone
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.